Bristol-Myers Squibb | BMY - Ebitda

Stock Price
58.71
Daily Change
-0.31 -0.53%
Monthly
-0.39%
Yearly
22.57%
Q2 Forecast
57.45

Bristol-Myers Squibb reported $4.24B in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
AbbVie USD 3.52B 828M Sep/2025
Abbott USD 3.27B 178M Dec/2025
ALKERMES USD 100.31M 21.24M Dec/2025
Amgen USD 5.14B 775M Dec/2025
AstraZeneca USD 5.23B 272M Sep/2025
Biogen USD 573.2M 253.7M Dec/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Coherus Biosciences USD -43.33M 4.7M Sep/2025
Drreddys Laboratories INR 21.59B 1.49B Dec/2025
Eli Lilly USD 7.88B 378.1M Sep/2025
Gilead Sciences USD 3.02B 1.01B Dec/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
J&J USD 7.19B 2.32B Dec/2025
Medtronic USD 2.93B 482M Dec/2025
Merck USD 8.39B 1.97B Sep/2025
Novartis USD 4.77B 1.11B Dec/2025
Novo Nordisk DKK 37.3B 5.86B Dec/2025
Perrigo USD 258.8M 37.3M Sep/2025
Pfizer USD 6.08B 351M Sep/2025
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Prestige Brands USD 90.82M 3.99M Dec/2025
Regeneron Pharmaceuticals USD 1.92B 261.9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 3.31B 3.65B Mar/2026
Sanofi EUR 5.66B 3.77B Sep/2025
United Therapeutics USD 379.5M 83.4M Dec/2025
Zoetis USD 1.04B 87M Sep/2025